FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Retatrutide 10mg
Triple-agonist metabolic research peptide.
Total: $119.99 · USD
FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Common questions
For laboratory and clinical-research professionals.
Is this for human use?+
No. This product is sold strictly as a research reference material. FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
How is purity verified?+
Each batch is analyzed via HPLC and mass spectrometry. A certificate of analysis is available on request.
How should this compound be stored?+
Store lyophilized at −20°C. Once reconstituted, store at 2–8°C and use within the validated stability window of your protocol.
Do you ship internationally?+
We currently ship within the United States. International research-facility inquiries should contact our wholesale desk.
Do you provide a COA?+
Yes — lot-specific Certificates of Analysis are available on request via the contact form.
About Retatrutide
Reference profile for laboratory researchers.
Retatrutide is a synthetic peptide referenced in published in-vitro literature as a triple agonist with reported activity at GIP, GLP-1 and glucagon receptor binding sites. Peptide Clinic of Los Angeles supplies Retatrutide as a lyophilized reference material strictly for laboratory and research use.
Each lot is tested by HPLC for purity (≥99%) and confirmed by mass spectrometry for identity. A lot-specific Certificate of Analysis is available with every shipment.
Researchers commonly reconstitute lyophilized Retatrutide in bacteriostatic water for short-term in-vitro assay preparation, with stability validated against the user's own protocol.
From researchers
Consistent batch quality
Our lab has standardized on Peptide Clinic for reference material. COA on every lot.
— Dr. R., Independent Lab
Fast and discreet
Cold-chain arrived within 48 hours, packaging was immaculate.
— M.K., Research Facility
High purity verified
Confirmed ≥99% via in-house HPLC against the provided COA.
— S.L., Biotech Startup